Skip to main content
User Image

Haitham Fady Mohamed Mostafa

Lecturer

Pharmaceutics departmaent

كلية الصيدلة
AB 33/8
publication
Journal Article
2011

Assessment of the pharmaceutical quality of marketed enteric coated pantoprazole sodium sesquihydrate products

Mostafa, Haitham F. . 2011

Enteric coating pantoprazole sodium sesquihydrate quality control

Pantoprazole sodium sesquihydrate (PSS) is a proton pump inhibitor, used in acid-related disorders, like peptic ulcer and gastroesophageal reflux. Increasing the number of pantoprazole containing products in the market, raises questions of its efficacy and generic substitution. The pharmaceutical quality of 6 generic PSS enteric coated tablets in 2 local markets was assessed relative to the innovator product (pantozol®). Uniformity of dosage unit, disintegration and in vitro drug release were determined using United States pharmacopeia for delayed release tablets. The similarity factor (f2) was assessed using the FDA recommended approach (f2 similarity factor). The content uniformity of the innovator product was 98.39% of the labeled claim with RSD value of 1.08%, while the content of generic products ranged from 96.98% to 98.80% with RSD values of 1.24–2.19%. All the products showed no disintegration, cracks or swelling in 0.1 N HCl, except product 1, which showed complete disintegration after 20 min. However, the disintegration of all the products in phosphate buffer met USP requirements. Dissolution of tablets in 0.1 N HCl showed no drug release after 2 h except product 1 in which one tablet showed a drug release more than 10% at acid stage level A1. In addition, three tablets of this product showed dissolution of 45%, 48% and 69% at acid stage level A2. The similarity factor f2 of the products was between 71 and 74 indicating the similarity in dissolution profiles of all the products in accordance to FDA requirements, except product 1 in which f2 value was 18.67.

Publication Work Type
Research work
Volume Number
19
Issue Number
2
Magazine \ Newspaper
Saudi pharmaceutical journal
Pages
123-127
more of publication
publications

The objective of this work is to develop a simple inexpensive
method for manufacturing dextromethorphan hydrobromide
oral disintegrating tablets (ODTs) and to study the effect of…

by Haitham F. Mostafa, Mohamed A. Ibrahima, Adel Sakr
2014
publications

Orally disintegrating tablets (ODTs), which disintegrate rapidly (<1 min) in the mouth and do not require water for administration, have become a very popular dosage form. The study aims to…

by Haitham Fady Mostafa, Mohamed Abbas Ibrahim, Adel Sakr
2013
publications

Pantoprazole sodium sesquihydrate (PSS) is a proton pump inhibitor, used in acid-related disorders, like peptic ulcer and gastroesophageal reflux. Increasing the number of pantoprazole containing…

by Haitham F. Mostafa, Mohamed A. Ibrahima, Gamal M. Mahrous, Adel Sakr
2011